• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验性乳腺癌模型:临床前成像视角。

Experimental Breast Cancer Models: Preclinical Imaging Perspective.

机构信息

Department of Nuclear Medicine, Faculty of Medicine, Trakya University, Edirne, Turkey.

出版信息

Curr Radiopharm. 2021;14(1):5-14. doi: 10.2174/1874471013666200508080250.

DOI:10.2174/1874471013666200508080250
PMID:32384044
Abstract

BACKGROUND

Breast cancer is the leading cause of cancer in women. 13% of breast cancer patients are at a distant stage and mortality is due to metastases rather than primary disease. The unique genetic structure and natural process of breast cancer make it a very suitable area for targeted therapies. Experimental tumor models are validated methods to examine the pathogenesis of cancer, the onset of the neoplastic process and progression.

OBJECTIVE

This study aims to review the current literature on experimental breast cancer models and to bring a new perspective to the use of these models in teranostic preclinical studies in terms of the imaging.

METHODS

Search for relevant literature from academic databases using keywords (Breast cancer, theranostic, preclinical imaging, tumor models, animal study, and tailored therapy) was conducted. The full text of the articles was reached and reviewed. Current scientific data has been reevaluated and compiled according to subtitles.

RESULTS AND CONCLUSION

The development of animal models for breast cancer research has been done in the last century. Imaging methods used in breast cancer are used for tumor localization, quantification of tumor mass, imaging of genes and proteins, evaluation of tumor microenvironment, evaluation of tumor cell proliferation and metabolism and treatment response evaluation. Since human breast cancer is a heterogeneous group of diseases in terms of genetics and phenotype; it is not possible for a single model to adequately address all aspects of breast cancer biology. Considering that each model has advantages and disadvantages, the most suitable model should be chosen to verify the thesis of the study.

摘要

背景

乳腺癌是女性癌症的主要病因。13%的乳腺癌患者处于晚期,其死亡率是由转移而不是原发性疾病引起的。乳腺癌独特的遗传结构和自然病程使其成为靶向治疗的非常合适的领域。实验性肿瘤模型是验证癌症发病机制、肿瘤发生和进展的方法。

目的

本研究旨在回顾目前关于实验性乳腺癌模型的文献,并从影像学角度为这些模型在治疗前临床研究中的应用带来新的视角。

方法

使用关键词(乳腺癌、治疗诊断、临床前影像学、肿瘤模型、动物研究和靶向治疗)在学术数据库中搜索相关文献。获取并回顾文章的全文。根据副标题重新评估和编译当前的科学数据。

结果与结论

在过去的几十年中,已经为乳腺癌研究开发了动物模型。用于乳腺癌的成像方法用于肿瘤定位、肿瘤质量定量、基因和蛋白质成像、肿瘤微环境评估、肿瘤细胞增殖和代谢评估以及治疗反应评估。由于人类乳腺癌在遗传和表型方面是一组异质性疾病,因此单一模型不可能充分解决乳腺癌生物学的所有方面。鉴于每种模型都有其优缺点,应选择最合适的模型来验证研究的假设。

相似文献

1
Experimental Breast Cancer Models: Preclinical Imaging Perspective.实验性乳腺癌模型:临床前成像视角。
Curr Radiopharm. 2021;14(1):5-14. doi: 10.2174/1874471013666200508080250.
2
Preclinical Molecular Imaging for Precision Medicine in Breast Cancer Mouse Models.临床前分子成像在乳腺癌小鼠模型精准医学中的应用
Contrast Media Mol Imaging. 2019 Sep 22;2019:8946729. doi: 10.1155/2019/8946729. eCollection 2019.
3
Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging.通过靶向B7-H3的超声分子成像检测乳腺癌
Cancer Res. 2015 Jun 15;75(12):2501-9. doi: 10.1158/0008-5472.CAN-14-3361. Epub 2015 Apr 21.
4
A rapid and quantitative method to detect human circulating tumor cells in a preclinical animal model.一种在临床前动物模型中检测人循环肿瘤细胞的快速定量方法。
BMC Cancer. 2017 Jun 23;17(1):440. doi: 10.1186/s12885-017-3419-x.
5
Mouse Models of Breast Cancer: Platforms for Discovering Precision Imaging Diagnostics and Future Cancer Medicine.乳腺癌小鼠模型:发现精准影像诊断和未来癌症医学的平台。
J Nucl Med. 2016 Feb;57 Suppl 1(Suppl 1):60S-8S. doi: 10.2967/jnumed.115.157917.
6
F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.F-18氟脱氧葡萄糖正电子发射断层扫描在乳腺癌患者随访中诊断肿瘤复发和转移:与传统成像的比较
Invest Radiol. 2003 May;38(5):250-6. doi: 10.1097/01.RLI.0000063983.86229.f2.
7
Overview of resistance to systemic therapy in patients with breast cancer.乳腺癌患者全身治疗耐药概述。
Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1.
8
Clinically relevant dual probe difference specimen imaging (DDSI) protocol for freshly resected breast cancer specimen staining.临床相关的双探头差异标本成像(DDSI)方案,用于新鲜切除的乳腺癌标本染色。
BMC Cancer. 2021 Apr 21;21(1):440. doi: 10.1186/s12885-021-08179-8.
9
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
10
Animal Models for the Evaluation of Theranostic Radiopharmaceuticals.治疗放射性药物的评价的动物模型。
Curr Radiopharm. 2021;14(1):15-22. doi: 10.2174/1874471013666200425223428.

引用本文的文献

1
Realistic aspects behind the application of the rat model of chemically-induced mammary cancer: Practical guidelines to obtain the best results.化学诱导性乳腺癌大鼠模型应用背后的现实因素:获取最佳结果的实用指南
Vet World. 2023 Jun;16(6):1222-1230. doi: 10.14202/vetworld.2023.1222-1230. Epub 2023 Jun 5.
2
lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p.长链非编码 RNA ACTA2-AS1 预测三阴性乳腺癌的恶性程度和预后不良,并通过调节 miR-532-5p 来调节肿瘤进展。
BMC Mol Cell Biol. 2022 Jul 27;23(1):34. doi: 10.1186/s12860-022-00432-7.
3
One-Pot Synthesis of Novel 2-Imino-5-Arylidine-Thiazolidine Analogues and Evaluation of Their Anti-Proliferative Activity against MCF7 Breast Cancer Cell Line.
一锅法合成新型 2-亚氨基-5-芳基亚甲基噻唑烷类似物及其对 MCF7 乳腺癌细胞系的抗增殖活性评价。
Molecules. 2022 Jan 27;27(3):841. doi: 10.3390/molecules27030841.
4
Engineering Breast Cancer Cells and hUMSCs Microenvironment in 2D and 3D Scaffolds: A Mechanical Study Approach of Stem Cells in Anticancer Therapy.在二维和三维支架中构建乳腺癌细胞与人间充质干细胞微环境:抗癌治疗中干细胞的力学研究方法
Bioengineering (Basel). 2021 Nov 20;8(11):189. doi: 10.3390/bioengineering8110189.